Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Amorphus Globosus Foetuses in Polish Holstein Cattle: Anatomical, Histological, and Genetic Studies.

Gehrke M, Blaszak B, Stachowiak M, Szczerbal I, Stefańska B, Jaśkowski JM, Nowak W, Świtoński M.

J Vet Res. 2019 Sep 13;63(3):391-398. doi: 10.2478/jvetres-2019-0057. eCollection 2019 Sep.

2.

Resynchronisation as an Element of Improving Cattle Reproduction Efficiency.

Jaśkowski JM, Gehrke M, Herudzińska M, Jaśkowski BM, Brüssow KP.

J Vet Res. 2019 Mar 22;63(1):107-115. doi: 10.2478/jvetres-2019-0009. eCollection 2019 Mar.

3.

Hybrid Ear Cubes for local controlled dexamethasone delivery to the inner ear.

Gehrke M, Verin J, Gnansia D, Tourrel G, Risoud M, Vincent C, Siepmann F, Siepmann J.

Eur J Pharm Sci. 2019 Jan 1;126:23-32. doi: 10.1016/j.ejps.2018.04.045. Epub 2018 May 1.

PMID:
29723597
4.

Factors Influencing Caregiver Decision Making to Change the Communication Method of their Child with Hearing Loss.

Scarinci NA, Gehrke MJ, Ching TYC, Marnane V, Button L.

Deafness Educ Int. 2018;20(3-4):123-153. doi: 10.1080/14643154.2018.1511239. Epub 2018 Aug 27.

5.

Relationship between pH of ruminal fluid during subacute ruminal acidosis and physiological response of the Polish Holstein-Friesian dairy cows.

Stefańska B, Pruszyńska-Oszmałek E, Szczepankiewicz D, Stajek K, Stefański P, Gehrke M, Nowak W.

Pol J Vet Sci. 2017 Sep 26;20(3):551-558. doi: 10.1515/pjvs-2017-0067.

PMID:
29166264
6.

Limited drug solubility can be decisive even for freely soluble drugs in highly swollen matrix tablets.

Siepmann F, Karrout Y, Gehrke M, Penz FK, Siepmann J.

Int J Pharm. 2017 Jun 30;526(1-2):280-290. doi: 10.1016/j.ijpharm.2017.05.001. Epub 2017 May 6.

PMID:
28487190
7.

Can the Palatability of Healthy, Satiety-Promoting Foods Increase with Repeated Exposure during Weight Loss?

Anguah KO, Lovejoy JC, Craig BA, Gehrke MM, Palmer PA, Eichelsdoerfer PE, McCrory MA.

Foods. 2017 Feb 22;6(2). pii: E16. doi: 10.3390/foods6020016.

8.

Bovine Neonatal Pancytopenia - correlation between clinical symptoms, hematological parameters and lifespan.

Gehrke M, Junge V, Jaśkowski JM, Polak MP, Urbaniak K, Żuraw A.

Tierarztl Prax Ausg G Grosstiere Nutztiere. 2016 Dec 5;44(6):355-359. Epub 2016 Nov 2.

PMID:
27805246
9.

Ear Cubes for local controlled drug delivery to the inner ear.

Gehrke M, Sircoglou J, Gnansia D, Tourrel G, Willart JF, Danede F, Lacante E, Vincent C, Siepmann F, Siepmann J.

Int J Pharm. 2016 Jul 25;509(1-2):85-94. doi: 10.1016/j.ijpharm.2016.04.003. Epub 2016 Apr 2.

PMID:
27050866
10.

How to adjust dexamethasone mobility in silicone matrices: A quantitative treatment.

Gehrke M, Sircoglou J, Vincent C, Siepmann J, Siepmann F.

Eur J Pharm Biopharm. 2016 Mar;100:27-37. doi: 10.1016/j.ejpb.2015.11.018. Epub 2015 Dec 11.

PMID:
26686648
11.

Durable sequence stability and bone marrow tropism in a macaque model of human pegivirus infection.

Bailey AL, Lauck M, Mohns M, Peterson EJ, Beheler K, Brunner KG, Crosno K, Mejia A, Mutschler J, Gehrke M, Greene J, Ericsen AJ, Weiler A, Lehrer-Brey G, Friedrich TC, Sibley SD, Kallas EG, Capuano S 3rd, Rogers J, Goldberg TL, Simmons HA, O'Connor DH.

Sci Transl Med. 2015 Sep 16;7(305):305ra144. doi: 10.1126/scitranslmed.aab3467.

12.

Trans-Oval-Window Implants, A New Approach for Drug Delivery to the Inner Ear: Extended Dexamethasone Release From Silicone-based Implants.

Sircoglou J, Gehrke M, Tardivel M, Siepmann F, Siepmann J, Vincent C.

Otol Neurotol. 2015 Sep;36(9):1572-9. doi: 10.1097/MAO.0000000000000855.

PMID:
26375981
13.

Antiinflammatory Activity of a Novel Folic Acid Targeted Conjugate of the mTOR Inhibitor Everolimus.

Lu Y, Parker N, Kleindl PJ, Cross VA, Wollak K, Westrick E, Stinnette TW, Gehrke MA, Wang K, Santhapuram HK, You F, Hahn SJ, Vaughn JF, Klein PJ, Vlahov IR, Low PS, Leamon CP.

Mol Med. 2015 Jul 8;21:584-96. doi: 10.2119/molmed.2015.00040.

14.

Adiposity rebound is misclassified by BMI rebound.

Plachta-Danielzik S, Bosy-Westphal A, Kehden B, Gehrke MI, Kromeyer-Hauschild K, Grillenberger M, Willhöft C, Heymsfield SB, Müller MJ.

Eur J Clin Nutr. 2013 Sep;67(9):984-9. doi: 10.1038/ejcn.2013.131. Epub 2013 Jul 17.

PMID:
23859998
15.
16.

Predicting drug release from HPMC/lactose tablets.

Siepmann J, Karrout Y, Gehrke M, Penz FK, Siepmann F.

Int J Pharm. 2013 Jan 30;441(1-2):826-34. doi: 10.1016/j.ijpharm.2012.12.009. Epub 2012 Dec 20.

PMID:
23262427
17.

[Longitudinal data of the Kiel Obesity Prevention Study (KOPS)].

Plachta-Danielzik S, Landsberg B, Seiberl J, Gehrke MI, Gose M, Kehden B, Müller MJ.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012 Jun;55(6-7):885-91. doi: 10.1007/s00103-012-1494-3. German.

PMID:
22736171
18.

Body fat percentiles for German children and adolescents.

Plachta-Danielzik S, Gehrke MI, Kehden B, Kromeyer-Hauschild K, Grillenberger M, Willhöft C, Bosy-Westphal A, Müller MJ.

Obes Facts. 2012;5(1):77-90. doi: 10.1159/000336780. Epub 2012 Mar 2.

19.

Treatment of experimental adjuvant arthritis with a novel folate receptor-targeted folic acid-aminopterin conjugate.

Lu Y, Stinnette TW, Westrick E, Klein PJ, Gehrke MA, Cross VA, Vlahov IR, Low PS, Leamon CP.

Arthritis Res Ther. 2011 Apr 4;13(2):R56. doi: 10.1186/ar3304.

20.

Reducing undesirable hepatic clearance of a tumor-targeted vinca alkaloid via novel saccharopeptidic modifications.

Leamon CP, Reddy JA, Klein PJ, Vlahov IR, Dorton R, Bloomfield A, Nelson M, Westrick E, Parker N, Bruna K, Vetzel M, Gehrke M, Nicoson JS, Messmann RA, LoRusso PM, Sausville EA.

J Pharmacol Exp Ther. 2011 Feb;336(2):336-43. doi: 10.1124/jpet.110.175109. Epub 2010 Oct 26.

PMID:
20978169
21.

Selected biochemical blood compounds in cows with abomasum displacement.

Markiewicz H, Gehrke M, Malinowski E.

Pol J Vet Sci. 2009;12(4):515-8.

PMID:
20169926
22.

Development and validation of an LC-MS/MS method for the determination of quetiapine and four related metabolites in human plasma.

Davis PC, Bravo O, Gehrke M, Azumaya CT.

J Pharm Biomed Anal. 2010 Apr 6;51(5):1113-9. doi: 10.1016/j.jpba.2009.11.018. Epub 2009 Nov 24.

PMID:
20022726
23.

Long-acting methylphenidate has an effect on aggressive behavior in children with attention-deficit/hyperactivity disorder.

Sinzig J, Döpfner M, Lehmkuhl G; German Methylphenidate Study Group, Uebel H, Schmeck K, Poustka F, Gerber WD, Günter M, Knölker U, Gehrke M, Hässler F, Resch F, Brünger M, Ose C, Fischer R.

J Child Adolesc Psychopharmacol. 2007 Aug;17(4):421-32.

PMID:
17822338
24.

Damage control resuscitation: directly addressing the early coagulopathy of trauma.

Holcomb JB, Jenkins D, Rhee P, Johannigman J, Mahoney P, Mehta S, Cox ED, Gehrke MJ, Beilman GJ, Schreiber M, Flaherty SF, Grathwohl KW, Spinella PC, Perkins JG, Beekley AC, McMullin NR, Park MS, Gonzalez EA, Wade CE, Dubick MA, Schwab CW, Moore FA, Champion HR, Hoyt DB, Hess JR.

J Trauma. 2007 Feb;62(2):307-10. No abstract available.

PMID:
17297317
25.
26.

Rupture of a saphenous vein coronary artery bypass graft due to Aspergillus necrotizing vasculitis.

Draganov J, Klein HM, Ghodsizad A, Gehrke M, Gams E.

Ann Thorac Surg. 2005 Aug;80(2):724-6.

PMID:
16039244
27.

Subcellular localization of collapsin response mediator proteins to lipid rafts.

Rosslenbroich V, Dai L, Franken S, Gehrke M, Junghans U, Gieselmann V, Kappler J.

Biochem Biophys Res Commun. 2003 May 30;305(2):392-9.

PMID:
12745088
28.

High-throughput peptide synthesis and peptide purification strategy at the low micromol-scale using the 96-well format.

Pipkorn R, Boenke C, Gehrke M, Hoffmann R.

J Pept Res. 2002 Mar;59(3):105-14.

PMID:
11985704
29.

A high efficiency all glass sampling and concentration device for adsorptive semivolatile organics.

Gehrke M, Kapila CS, Nam P, Flanigan V.

Chemosphere. 2001 May-Jun;43(4-7):479-83.

PMID:
11372829
30.
31.

Coping with hallucinations: exploring stress and coping framework.

Farhall J, Gehrke M.

Br J Clin Psychol. 1997 May;36(2):259-61.

PMID:
9167865
32.
33.

Effect of recombinant beet necrotic yellow vein virus with different RNA compositions on mechanically inoculated sugarbeets.

Koenig R, Jarausch W, Li Y, Commandeur U, Burgermeister W, Gehrke M, Lüddecke P.

J Gen Virol. 1991 Sep;72 ( Pt 9):2243-6.

PMID:
1895061
34.

Complexation and medium effects on the conformation of cyclosporin A studied by NMR spectroscopy and molecular dynamics calculations.

Kessler H, Gehrke M, Lautz J, Köck M, Seebach D, Thaler A.

Biochem Pharmacol. 1990 Jul 1;40(1):169-73. Erratum in: Biochem Pharmacol 1990 Nov 1;40(9):2185-6.

PMID:
2164815
35.

[Appropriate retainers for orthodontic plate appliances in the deciduous and mixed dentition].

Gehrke ME.

Quintessenz Zahntech. 1987 Feb;13(2):193-8. German. No abstract available.

PMID:
3473570
36.

[The saw frame in orthodontic technic].

Gehrke ME.

Quintessenz Zahntech. 1986 Sep;12(9):935-8. German. No abstract available.

PMID:
3541023
37.

[The finishing of a 3-cornered clasp].

Gehrke ME.

Quintessenz Zahntech. 1986 Jun;12(6):651-9. German. No abstract available.

PMID:
3529218
38.

Common structural features for cytoprotection activities of somatostatin, antamanide and related peptides.

Kessler H, Gehrke M, Haupt A, Klein M, Müller A, Wagner K.

Klin Wochenschr. 1986;64 Suppl 7:74-8. No abstract available.

PMID:
2882054
39.

[Problems of double expansion plates with guide brackets].

Gehrke ME.

Quintessenz Zahntech. 1985 Dec;11(12):1407-16. German. No abstract available.

PMID:
3915119
40.

[Insulation in the production of orthodontic appliances].

Gehrke ME.

Quintessenz Zahntech. 1985 Apr;11(4):429-34. German. No abstract available.

PMID:
3862176
41.

[Thoughts on finishing of a Y-plate].

Gehrke ME.

Quintessenz Zahntech. 1984 Sep;10(9):1031-9. German. No abstract available.

PMID:
6396688
42.

[Examination of the Adams clasp].

Gehrke ME.

Quintessenz Zahntech. 1984 May;10(5):569-78. German. No abstract available.

PMID:
6592670
43.

[The question of reciprocal force in the use of expansion screws in orthodontic appliance technics].

Gehrke ME.

Quintessenz Zahntech. 1983 Oct;9(10):1061-7. German. No abstract available.

PMID:
6366889
44.

[Bimaxillary treatment appliance in orthodontics (II)].

Gehrke ME.

Quintessenz Zahntech. 1982 Aug;8(8):883-90. German. No abstract available.

PMID:
6964428
45.

[Bimaxillary treatment appliance in orthodontics (I)].

Gehrke ME.

Quintessenz Zahntech. 1982 Jul;8(7):797-805. German. No abstract available.

PMID:
6962969
46.

[Manufacture of positioners].

Gehrke ME.

Quintessenz Zahntech. 1982 Apr;8(4):491-500. German. No abstract available.

PMID:
6955890
47.

[Removable orthodontic appliances as preparatory measures for patients treatment (II)].

Gehrke ME.

Quintessenz Zahntech. 1981 Oct;7(10):965-70. German. No abstract available.

PMID:
6952510
48.

[Removable orthodontic appliances as preparatory measures for patient treatment (I)].

Gehrke ME.

Quintessenz Zahntech. 1981 Sep;7(9):871-8. German. No abstract available.

PMID:
6952522
49.

[Epidemiologic experiences in poisonings in children].

Rechlin R, Breter H, Gehrke M, Szudra E, Willenberg R.

Z Arztl Fortbild (Jena). 1981 Jan 1;75(1):36-40. German. No abstract available.

PMID:
7222776
50.

Identifying brain tumors.

Gehrke M.

J Neurosurg Nurs. 1980 Dec;12(4):203-5. No abstract available.

PMID:
6906360

Supplemental Content

Loading ...
Support Center